SG Americas Securities LLC Takes Position in Masimo Co. (NASDAQ:MASI)

SG Americas Securities LLC purchased a new stake in Masimo Co. (NASDAQ:MASI - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 28,967 shares of the medical equipment provider's stock, valued at approximately $3,862,000. SG Americas Securities LLC owned about 0.05% of Masimo as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its position in Masimo by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 4,781,343 shares of the medical equipment provider's stock worth $560,421,000 after buying an additional 26,473 shares in the last quarter. Farallon Capital Management LLC grew its position in Masimo by 13.6% during the first quarter. Farallon Capital Management LLC now owns 1,489,563 shares of the medical equipment provider's stock worth $218,742,000 after buying an additional 177,914 shares in the last quarter. Thrivent Financial for Lutherans grew its position in Masimo by 42.1% during the second quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider's stock worth $153,314,000 after buying an additional 360,497 shares in the last quarter. Point72 Asset Management L.P. grew its position in Masimo by 107.8% during the second quarter. Point72 Asset Management L.P. now owns 677,677 shares of the medical equipment provider's stock worth $85,347,000 after buying an additional 351,523 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Masimo by 45.9% during the second quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider's stock worth $66,201,000 after buying an additional 165,257 shares in the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Trading Down 2.3 %

MASI stock traded down $3.16 during trading on Monday, hitting $135.67. The company had a trading volume of 2,128,297 shares, compared to its average volume of 683,008. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The firm has a 50-day moving average price of $119.78 and a 200-day moving average price of $124.96. Masimo Co. has a 12 month low of $75.22 and a 12 month high of $153.93. The stock has a market cap of $7.22 billion, a price-to-earnings ratio of 94.44 and a beta of 0.99.

Masimo (NASDAQ:MASI - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.77 by $0.09. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The firm had revenue of $496.30 million during the quarter, compared to analysts' expectations of $493.92 million. During the same quarter in the previous year, the company posted $0.62 EPS. Masimo's revenue was up 9.0% on a year-over-year basis. As a group, analysts predict that Masimo Co. will post 3.87 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Needham & Company LLC restated a "hold" rating on shares of Masimo in a research note on Friday, September 20th. Piper Sandler raised their price target on shares of Masimo from $160.00 to $165.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 7th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, Masimo has a consensus rating of "Moderate Buy" and an average target price of $144.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.